Skip to content

3Accepted Mar 25, 4:19 PM ET

Versant Venture Capital VII, L.P. 3

LENZLENZ Therapeutics, Inc.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

4:19 PM

Mar 25, 2024

Filed

Mar 25, 2024

Documents

1

Size

9.7 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.